These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 23098208)
1. p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells. Bisaro B; Montani M; Konstantinidou G; Marchini C; Pietrella L; Iezzi M; Galiè M; Orso F; Camporeale A; Colombo SM; Di Stefano P; Tornillo G; Camacho-Leal MP; Turco E; Taverna D; Cabodi S; Amici A; Defilippi P Breast Cancer Res; 2012 Oct; 14(5):R137. PubMed ID: 23098208 [TBL] [Abstract][Full Text] [Related]
2. A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo. Kumbrink J; de la Cueva A; Soni S; Sailer N; Kirsch KH Tumour Biol; 2016 Aug; 37(8):10665-73. PubMed ID: 26867768 [TBL] [Abstract][Full Text] [Related]
3. Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling. Garulli C; Kalogris C; Pietrella L; Bartolacci C; Andreani C; Falconi M; Marchini C; Amici A Cell Signal; 2014 Feb; 26(2):352-62. PubMed ID: 24280125 [TBL] [Abstract][Full Text] [Related]
4. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
5. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1. Tornillo G; Bisaro B; Camacho-Leal Mdel P; Galiè M; Provero P; Di Stefano P; Turco E; Defilippi P; Cabodi S Eur J Cell Biol; 2011; 90(2-3):237-48. PubMed ID: 20961652 [TBL] [Abstract][Full Text] [Related]
6. p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells. Cabodi S; Moro L; Baj G; Smeriglio M; Di Stefano P; Gippone S; Surico N; Silengo L; Turco E; Tarone G; Defilippi P J Cell Sci; 2004 Mar; 117(Pt 8):1603-11. PubMed ID: 15020686 [TBL] [Abstract][Full Text] [Related]
7. Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids. Konstantinovsky S; Davidson B; Reich R Clin Exp Metastasis; 2012 Aug; 29(6):527-40. PubMed ID: 22476538 [TBL] [Abstract][Full Text] [Related]
8. Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression. Zhao Y; Kumbrink J; Lin BT; Bouton AH; Yang S; Toselli PA; Kirsch KH Carcinogenesis; 2013 Dec; 34(12):2880-90. PubMed ID: 23825155 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer. Kang H; Kim C; Lee H; Rho JG; Seo JW; Nam JW; Song WK; Nam SW; Kim W; Lee EK Cell Death Differ; 2016 Mar; 23(3):484-95. PubMed ID: 26337669 [TBL] [Abstract][Full Text] [Related]
10. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis. Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336 [TBL] [Abstract][Full Text] [Related]
11. p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy. Bisaro B; Sciortino M; Colombo S; Camacho Leal MP; Costamagna A; Castellano I; Montemurro F; Rossi V; Valabrega G; Turco E; Defilippi P; Cabodi S Oncotarget; 2016 Jan; 7(4):4442-53. PubMed ID: 26716506 [TBL] [Abstract][Full Text] [Related]
12. AND-34/BCAR3 regulates adhesion-dependent p130Cas serine phosphorylation and breast cancer cell growth pattern. Makkinje A; Near RI; Infusini G; Vanden Borre P; Bloom A; Cai D; Costello CE; Lerner A Cell Signal; 2009 Sep; 21(9):1423-35. PubMed ID: 19454314 [TBL] [Abstract][Full Text] [Related]
13. Selective involvement of p130Cas/Crk/Pyk2/c-Src in endothelin-1-induced JNK activation. Kodama H; Fukuda K; Takahashi E; Tahara S; Tomita Y; Ieda M; Kimura K; Owada KM; Vuori K; Ogawa S Hypertension; 2003 Jun; 41(6):1372-9. PubMed ID: 12719447 [TBL] [Abstract][Full Text] [Related]
14. p130Cas Is Correlated with EREG Expression and a Prognostic Factor Depending on Colorectal Cancer Stage and Localization Reducing FOLFIRI Efficacy. Kumbrink J; Li P; Pók-Udvari A; Klauschen F; Kirchner T; Jung A Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830244 [TBL] [Abstract][Full Text] [Related]
15. CSRP2 suppresses colorectal cancer progression Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270 [TBL] [Abstract][Full Text] [Related]
16. Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death. Nick AM; Stone RL; Armaiz-Pena G; Ozpolat B; Tekedereli I; Graybill WS; Landen CN; Villares G; Vivas-Mejia P; Bottsford-Miller J; Kim HS; Lee JS; Kim SM; Baggerly KA; Ram PT; Deavers MT; Coleman RL; Lopez-Berestein G; Sood AK J Natl Cancer Inst; 2011 Nov; 103(21):1596-612. PubMed ID: 21957230 [TBL] [Abstract][Full Text] [Related]
19. p130Cas is an essential transducer element in ErbB2 transformation. Cabodi S; Tinnirello A; Bisaro B; Tornillo G; del Pilar Camacho-Leal M; Forni G; Cojoca R; Iezzi M; Amici A; Montani M; Eva A; Di Stefano P; Muthuswamy SK; Tarone G; Turco E; Defilippi P FASEB J; 2010 Oct; 24(10):3796-808. PubMed ID: 20505116 [TBL] [Abstract][Full Text] [Related]
20. Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis. Kessler BE; Mishall KM; Kellett MD; Clark EG; Pugazhenthi U; Pozdeyev N; Kim J; Tan AC; Schweppe RE Oncogene; 2019 Apr; 38(14):2565-2579. PubMed ID: 30531837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]